Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification (Agonist/Antagonist) and Regression "Structure-Activity" Models of Drug Interaction with 5-HT6.

Oleg A Raevsky1, Veniamin Y Grigorev1, Alexander V Yarkov1

  • 1Institute of Physiologically Active Compounds, Russian Academy of Sciences, Moscow Region 142432, Chernogolovka, Russian Federation.

Central Nervous System Agents in Medicinal Chemistry
|August 28, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KRASAVA-An Expert System for Virtual Screening of KRAS G12D Inhibitors.

International journal of molecular sciences·2026
Same author

Single- and Multiple-dose Pharmacokinetics, Excretion, Metabolism, and Safety of the Antivirulence Agent Fluorothiazinone in Healthy Adults.

Pharmaceutical research·2025
Same author

HDAC3_VS_assistant: cheminformatics-driven discovery of histone deacetylase 3 inhibitors.

Molecular diversity·2024
Same author

Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales.

Pharmacological research·2024
Same author

Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov.

Translational psychiatry·2024
Same author

Advances in development of biomarkers for brain damage and ischemia.

Molecular biology reports·2024
Same journal

Phyto-Nanotherapeutics for Alzheimer's Disease: Current Progress and Future Perspectives.

Central nervous system agents in medicinal chemistry·2026
Same journal

Cannabinoids for Neuropathic Pain: A Pharmacological Review of Mechanisms, Clinical Translation, and Future Directions.

Central nervous system agents in medicinal chemistry·2026
Same journal

Heterocyclic Scaffolds as Therapeutic Agents in Multiple Sclerosis: Mechanisms and SAR Study.

Central nervous system agents in medicinal chemistry·2026
Same journal

Bioinformatic Identification of Shared Gene Networks Between Weaning- Induced Intestinal Inflammation and Neuroinflammatory-Related Pathways.

Central nervous system agents in medicinal chemistry·2026
Same journal

Fluorinated Gamma-carboline Derivatives as Promising Neuroprotective Candidates. Structure-Activity Relationships.

Central nervous system agents in medicinal chemistry·2026
Same journal

D-galactose-induced Cognitive Impairment: Mechanism, Models and Therapeutic Interventions.

Central nervous system agents in medicinal chemistry·2026
See all related articles
This summary is machine-generated.

Quantitative Structure-Activity Relationship (QSAR) models reveal that hydrogen bond acceptor ability and hydrophobicity significantly influence 5-HT6 receptor ligand activity. These findings aid in designing novel psychotropic drugs targeting the 5-HT6 receptor.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Pharmacology

Background:

  • The 5-HT6 receptor, a G-Protein Coupled Receptor (GPCR), is a key target for novel psychotropic drugs.
  • Both agonists and antagonists of the 5-HT6 receptor show potential procognitive effects.

Purpose of the Study:

  • To perform a detailed Quantitative Structure-Activity Relationship (QSAR) analysis on 61 drugs targeting the 5-HT6 receptor.
  • To identify key molecular descriptors influencing ligand activity (agonist vs. antagonist) and potency.

Main Methods:

  • Utilized QSAR and molecular modeling on homology models due to the absence of an exact 5-HT6 receptor structure.
  • Employed five classification methods: k-Nearest Neighbors (k-NN), Logistic Regression (LG), Linear Discriminant Analysis (LDA), Random Forest (RF), and Support Vector Machine (SVM).
Keywords:
5-HT6 receptorCNS diseasesQSARclassificationmodellingregression.

Related Experiment Videos

  • Applied Multiple Regression Analysis (MRA) for regression analysis and Spectra of Inter Atomic Interactions (SIAI) to identify ligand interaction centers.

    • Main Results:

    • Developed SAR and QSAR models with cross-validated coefficients of determination of at least 0.80.
    • Identified hydrogen bond acceptor ability and hydrophobicity as predominant factors influencing ligand activity and inhibition degree.
    • Highlighted the importance of specific ligand centers interacting with the 5-HT6 receptor.

    Conclusions:

    • QSAR models effectively predict 5-HT6 receptor ligand activity based on molecular properties.
    • Hydrophobicity and hydrogen bond acceptor ability are critical for designing selective 5-HT6 receptor modulators.
    • The study provides valuable insights for the rational design of novel psychotropic agents targeting the 5-HT6 receptor.